S Paul1, A Keat. Show Affiliations » 1. Department of Rheumatology, Northwick Park Hospital, Harrow, Middlesex, UK.
Abstract
Entities: Disease Species
Mesh: See more » AdalimumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntirheumatic Agents/therapeutic useEtanerceptHumansImmunoglobulin G/therapeutic useImmunologic Factors/therapeutic useInfliximabReceptors, Tumor Necrosis Factor/therapeutic useSpondylarthropathies/drug therapySpondylitis, Ankylosing/drug therapyTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsImmunoglobulin GImmunologic FactorsReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximabAdalimumabEtanercept
Year: 2004 PMID: 15328421 DOI: 10.1093/rheumatology/keh358
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580